Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,Hyperammonaemia Knowledge Centre

    Launch of Hyperammonaemia Knowledge Centre

    Could you recognise the signs and symptoms of hyperammonaemia?
    Healthcare professionals have FREE access to a new educational resource providing up
    to date disease awareness information, treatment options, video channel and resources
    to help them quickly identify and treat this potentially life-threatening condition.

  • ,Bedwetting Knowledge Centre What's New

    Launch of the Updated Bedwetting
    Knowledge Centre

    The Bedwetting Knowledge Centre has been given a fresh new look with a
    mobile-responsive design. Users will be better able to use their mobile devices
    to explore sections on disease awareness, publication summaries and a case
    study-led CME activity with ease. Ensure you return to visit this resource often
    to avoid missing out on a number of upcoming content updates.

  • ,What's New Thrombosis Educational Portal

    Thrombosis Educational Portal (Advertorial)

    Containing sections on thrombosis, venous thromboembolism (VTE) prevention and
    treatment, atrial fibrillation, acute coronary syndrome (ACS) and quarterly-updated
    newsletters, the Thrombosis Educational Portal provides healthcare professionals
    with links to a comprehensive resource used in the treatment and management
    of venous and arterial thrombosis.

  • ,

    Launch of ‘IL-17A in Psoriasis’ section

    Located within the Psoriasis Knowledge Centre is a new IL-17A in Psoriasis
    educational area. This resource has been developed primarily to discuss the role
    of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential
    of treatments directed towards IL-17A. Users will find expert videos, clinical
    presentations on topics such as disease perception and emerging therapies, congress
    highlights, key publications and useful resources.

    This resource has been developed in collaboration with Novartis Pharma AG.

  • ,

    Launch of Obesity Learning Hub

    A learning hub has recently launched on epgonline.org offering comprehensive
    information on obesity. Healthcare professionals now have free access to the
    Knowledge Centre, EACCME-accredited European Obesity Initiative CME series
    and a range of additional resources including events information, news and
    journal articles, a clinical media library and patient guides.

Latest News

Mulpleta (lusutrombopag) is approved in Japan to treat thrombocytopenia associated with chronic liver disease- Shionogi


Shionogi has announced marketing approval in Japan for Mulpleta (lusutrombopag) tablets 3 mg for the improvement of thrombocytopenia-associated chronic liver disease patients undergoing an elective invasive procedure. Lusutrombopag is a small ...

Results of Phase III trial of MK 5172 + MK 8742 (grazoprevir + elbasvir) in hepatitis C plus CKD published in The Lancet- Merck


Merck announced the publication of results from C-SURFER, the first Phase III clinical trial to investigate MK 5172 + MK 8742 (grazoprevir + elbasvir), an all-oral, ribavirin-free chronic hepatitis C virus (HCV) treatment regimen in ...

Daklinza (daclatasvir) plus Sovaldi (sofosbuvir) filed with FDA for hepatitis C patients with HIV co-infection- BMS/Gilead Sciences


Bristol-Myers Squibb announced that the FDA has accepted for filing and review three supplemental New Drug Applications (sNDAs) for Daklinza (daclatasvir) with Sovaldi (sofosbuvir), from Gilead, with or without ribavirin. The applications are for the ...

Phase III study of Cotellic (cobimetinib) with Zelboraf (vemurafenib) meets secondary endpoint in metastatic melanoma- Exelixis/Genentech


Exelixis announced positive overall survival (OS) results from coBRIM, the phase III pivotal trial evaluating Cotellic (cobimetinib) in combination with Zelboraf (vemurafenib) in previously untreated patients with unresectable locally advanced or ...

FDA approves Aristada (aripiprazole lauroxil) for schizophrenia- Alkermes


The FDA has approved Aristada (aripiprazole lauroxil), from Alkermes, an extended-release injectable suspension for the treatment of schizophrenia. Aristada is an antipsychotic with once-monthly and six-week dosing options for delivering and ...

Cell Therapy plans a conditional authorisation for Heartcel for heart regeneration


Cell Therapy Ltd (CTL), a development stage biotechnology company with a portfolio of allogeneic regenerative medicines in clinical trials, announced that, following a pre-submission meeting with the European Medicines Agency (EMA) in September, CTL ...

New hyperammonaemia resource developed for EPGonline.org users


A Hyperammonaemia Knowledge Centre has launched on EPGonline.org to encourage healthcare professionals to recognise the signs and symptoms of this rare yet potentially life-threatening condition. Hyperammonaemia is a metabolic disturbance ...

Recent Updates


Clinical Guidelines

Management of Obesity in Adults: European Clinical Practice Guidelines

British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre-Operative Anaemia

Guidelines on the measurement of ultraviolet radiation levels in ultraviolet phototherapy: report issued by the British Association of Dermatologists and British Photodermatology Group 2015

Coeliac disease: recognition, assessment and management

Medical Journals

Predictors of Excess Weight Loss in Obese Patients After Gastric Bypass: a 60-Month Follow-up.

Virtual Reality-Enhanced Cognitive-Behavioral Therapy for Morbid Obesity: A Randomized Controlled Study with 1 Year Follow-Up.

Associations between poor sleep quality and different measures of obesity.

Assessing quality of life in severe obesity: development and psychometric properties of the ORWELL-R.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors